In post #478 we noted dephosphorylation and phosphorylation sites linked to Homo sapiens HDAC1 and chloroquine, which full text we cannot access. In the Bologna COVID-19 study (post #313), the serine-to-leucine at position 84 of COVID-19 ORF8:
'We analyzed the alternative isoforms of COVID-19 ORF8-aa84, dubbed ORF8-L (Leucine) and ORF8-S (Serine). Unfortunately, no crystal structures of close homologs to the ORF8 protein are available for a reliable homology modelling to measure the structural impact of this aminoacidic substitution. The closest 3D model to COVID-19 ORF8 available in Protein Data Bank is a short 22 amino acid stretch in the protein entry 6P65, with a non-significant E-value of 0.848. We therefore employed de novo methods to infer structural features of ORF8. One important effect we we could detect is a significant effect of Serine in ORF8-S in inducing structural disorder in the protein C-terminal portion, which is not predicted to be present in the ORF8-L, using the Russell/Linding algorithm. Moreover, it did not escape our attention that the ORF8-S could theoretically generate a novel phosphorylation target for the mammalian host Serine/Threonine kinases of the host organism. So, we searched for ORF8 homologous substrates in the Mammalia NCBI nr protein database, but could not find matches within E-value threshold of 1.'
(Ceraolo/Giorgi, Genomic Variance of the 2019-nCoV Coronavirus, op cit)
'We analyzed the alternative isoforms of COVID-19 ORF8-aa84, dubbed ORF8-L (Leucine) and ORF8-S (Serine). Unfortunately, no crystal structures of close homologs to the ORF8 protein are available for a reliable homology modelling to measure the structural impact of this aminoacidic substitution. The closest 3D model to COVID-19 ORF8 available in Protein Data Bank is a short 22 amino acid stretch in the protein entry 6P65, with a non-significant E-value of 0.848. We therefore employed de novo methods to infer structural features of ORF8. One important effect we we could detect is a significant effect of Serine in ORF8-S in inducing structural disorder in the protein C-terminal portion, which is not predicted to be present in the ORF8-L, using the Russell/Linding algorithm. Moreover, it did not escape our attention that the ORF8-S could theoretically generate a novel phosphorylation target for the mammalian host Serine/Threonine kinases of the host organism. So, we searched for ORF8 homologous substrates in the Mammalia NCBI nr protein database, but could not find matches within E-value threshold of 1.'
(Ceraolo/Giorgi, Genomic Variance of the 2019-nCoV Coronavirus, op cit)